中文产业新闻精选评分68Chinese source
BMS多发性骨髓瘤新药艾泊度胺获NMPA附条件批准，系全球首款CELMoD药物
全球首款，又一进口1类创新药国内获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
全球首款，又一进口1类创新药国内获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.